Dyadic International (DYAI) to Release Earnings on Wednesday

Dyadic International (NASDAQ:DYAI) is expected to be posting its quarterly earnings results before the market opens on Wednesday, March 26th. Analysts expect Dyadic International to post earnings of ($0.04) per share and revenue of $1.60 million for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.

Dyadic International Trading Down 2.8 %

Shares of DYAI opened at $1.37 on Tuesday. Dyadic International has a fifty-two week low of $0.93 and a fifty-two week high of $2.67. The stock has a fifty day moving average of $1.49 and a two-hundred day moving average of $1.42. The company has a debt-to-equity ratio of 1.54, a quick ratio of 5.15 and a current ratio of 5.15. The company has a market capitalization of $40.54 million, a PE ratio of -5.96 and a beta of 0.95.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Dyadic International stock. Bank of America Corp DE raised its position in Dyadic International, Inc. (NASDAQ:DYAI) by 16,146.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 27,132 shares of the biotechnology company’s stock after acquiring an additional 26,965 shares during the quarter. Bank of America Corp DE owned 0.09% of Dyadic International worth $47,000 at the end of the most recent quarter. Institutional investors and hedge funds own 27.95% of the company’s stock.

About Dyadic International

Dyadic International, Inc, a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health.